Monoallelic deletion of BCMA is a frequent feature in multiple myeloma

被引：4

作者：

Samur, Mehmet Kemal ^{[1
,2
,7
]}

Samur, Anil Aktas ^{[1
,3
]}

Corre, Jill ^{[4
]}

Lannes, Romain ^{[1
]}

Shah, Parth ^{[5
]}

Anderson, Kenneth ^{[3
]}

Avet-Loiseau, Herve ^{[4
]}

Munshi, Nikhil ^{[3
,6
,8
]}

机构：

[1] Dana Farber Canc Inst, Dept Data Sci, Boston, MA USA

[2] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA

[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[4] Univ Canc Ctr Toulouse Inst Natl St, Unit Genom Myeloma, Toulouse, France

[5] Dartmouth Hitchcock Med Ctr, Endocrinol Sect, Lebanon, NH USA

[6] Vet Affairs Boston Healthcare Syst, Boston, MA USA

[7] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA

[8] Dana Farber Canc Inst, Dept Data Sci, 450 Brookline Ave, Boston, MA 02215 USA

来源：

BLOOD ADVANCES | 2023年 / 7卷 / 21期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1182/bloodadvances.2023010025

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：6599 / 6603

页数：5

共 50 条

[1] Monoallelic deletion of BCMA locus is a frequent feature in MM and is associated with increased genomic loss
Samur, Mehmet K.
Aktas-Samur, Anil
Lannes, Romain
Corre, Jill
Anderson, Kenneth
Avet-Loiseau, Herve
Munshi, Nikhil C.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S14 - S14
[2] Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma
Da Via, Matteo C.
Dietrich, Oliver
Truger, Marietta
Arampatzi, Panagiota
Duell, Johannes
Heidemeier, Anke
Zhou, Xiang
Danhof, Sophia
Kraus, Sabrina
Chatterjee, Manik
Meggendorfer, Manja
Twardziok, Sven
Goebeler, Maria-Elisabeth
Topp, Max S.
Hudecek, Michael
Prommersberger, Sabrina
Hege, Kristen
Kaiser, Shari
Fuhr, Viktoria
Weinhold, Niels
Rosenwald, Andreas
Erhard, Florian
Haferlach, Claudia
Einsele, Hermann
Kortuem, K. Martin
Saliba, Antoine-Emmanuel
Rasche, Leo
NATURE MEDICINE, 2021, 27 (04) : 616 - 619
[3] Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma
Matteo C. Da Vià
Oliver Dietrich
Marietta Truger
Panagiota Arampatzi
Johannes Duell
Anke Heidemeier
Xiang Zhou
Sophia Danhof
Sabrina Kraus
Manik Chatterjee
Manja Meggendorfer
Sven Twardziok
Maria-Elisabeth Goebeler
Max S. Topp
Michael Hudecek
Sabrina Prommersberger
Kristen Hege
Shari Kaiser
Viktoria Fuhr
Niels Weinhold
Andreas Rosenwald
Florian Erhard
Claudia Haferlach
Hermann Einsele
K. Martin Kortüm
Antoine-Emmanuel Saliba
Leo Rasche
Nature Medicine, 2021, 27 : 616 - 619
[4] P53 deletion is not a frequent event in multiple myeloma
Avet-Loiseau, H
Li, JY
Godon, C
Morineau, N
Daviet, A
Harousseau, JL
Facon, T
Bataille, R
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (03) : 717 - 719
[5] Targeting BCMA in Multiple Myeloma
Tan, Carlyn Rose
Shah, Urvi A.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (05) : 367 - 383
[6] Targeting BCMA in Multiple Myeloma
Carlyn Rose Tan
Urvi A. Shah
Current Hematologic Malignancy Reports, 2021, 16 : 367 - 383
[7] BCMA Offers Hope in Multiple Myeloma
Hennessy, Mike, Sr.
ONCOLOGY-NEW YORK, 2020, 34 (11): : 458 - 458
[8] The Impact of Soluble BCMA and BCMA Gain on Anti-BCMA Immunotherapies in Multiple Myeloma
Lee, Holly
Durante, Michael
Ahn, Sungwoo
Leblay, Noemie
Poorebrahim, Mansour
Maity, Ranjan
Tilmont, Remi
Barakat, Elie
Jung, David
Ziccheddu, Bachisio
Brake, Alexis
Landgren, Ola
Diamond, Benjamin
Maura, Francesco
Neri, Paola
Bahlis, Nizar J.
BLOOD, 2023, 142
[9] Statistical analysis for rb-1 monoallelic deletion by FISH is crucial in multiple myeloma diagnosis.
Lu, G
Best, RG
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 70 - 70
[10] BCMA-targeted immunotherapy for multiple myeloma
Yu, Bo
Jiang, Tianbo
Liu, Delong
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)

← 1 2 3 4 5 →